🔴 Viking Therapeutics is trading 4.1% down today after pricing a discounted $500 million financing

Viking Therapeutics is trading at $35.24, down 4.11%, as financing pressure weighs on the shares.

• On September 24, the company priced a $500 million financing: 7,857,143 shares at $35.00 and $225 million of convertible notes.
• The share offering was below the September 23 close of $41.65, heightening dilution concerns and triggering a financing-driven selloff.
• The broader market is higher, making company-specific financing pressure the dominant explanation.